Compare RVSN & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | RVSN | COCH |
|---|---|---|
| Founded | 2016 | 1995 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | | Blank Checks |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.1M | 24.4M |
| IPO Year | 2022 | N/A |
| Metric | RVSN | COCH |
|---|---|---|
| Price | $0.34 | $0.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $9.50 |
| AVG Volume (30 Days) | ★ 762.4K | 458.6K |
| Earning Date | 02-03-2026 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $776,000.00 | $208,000.00 |
| Revenue This Year | $1,861.54 | N/A |
| Revenue Next Year | N/A | $29.53 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.27 | $0.64 |
| 52 Week High | $2.72 | $2.25 |
| Indicator | RVSN | COCH |
|---|---|---|
| Relative Strength Index (RSI) | 40.77 | 46.74 |
| Support Level | $0.36 | $0.80 |
| Resistance Level | $0.40 | $0.86 |
| Average True Range (ATR) | 0.03 | 0.05 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 2.26 | 16.62 |
Rail Vision Ltd is a development-stage technology company that is engaged in the design, development, and assembly of railway detection systems designed to solve the challenges in railway operational safety, efficiency, and predictive maintenance. Its railway detection systems include different types of cameras, including optics, visible light spectrum cameras (video), and thermal cameras that transmit data to a ruggedized onboard computer which is designed to be suitable for the rough environment of a train's locomotive. It has developed its railway detection and systems to save lives, increase efficiency, and dramatically reduce expenses for the railway operator.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.